The Food and Drug Administration (FDA) is considering possible regulatory action, due to a spike in reported adverse events associated with the drug Addyi (flibanserin), which is indicated for ...
Digital Journal reported on August 18, 2015, that Addyi, a drug that works on the brain to boost younger women’s libido if they have lost interest in sex, was given approval by the Food and Drug ...
IRVINE, CA – July 5, 2023 – The Ad Firm is thrilled to announce the publication of an abstract by Sprout Pharmaceuticals, showcasing the remarkable effects of Addyi (flibanserin) on low libido among ...
Addyi, sometimes referred to as "female Viagra," is now approved for use to treat low sex drive in postmenopausal women. MoMo Productions/Getty Images The Food and Drug Administration (FDA) expanded ...
In the often unspoken world of female sexual health, a revolution has started, and it began with the introduction of a unique medication called Addyi. Traditionally, when we think of sexual ...
Sprout joins the ranks of biotech's biggest names following record-setting growth, expanding prescriber adoption, and increasing payer coverage RALEIGH, N.C., April 29, 2026 /PRNewswire/ -- TIME has ...
The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images Postmenopause refers to the time period after the person finishes menopause and no longer has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results